Skip to content

Cerebrospinal Fluid Hypocretin and Nightmares in Dementia Syndromes.

Lynn Marie Trotti, Donald L. Bliwise, Glenda L Keating, David B Rye, William T Hu

Dementia and geriatric cognitive disorders extra 2021 DOI: 10.1159/000509585 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cross-sectional study Peer reviewed
Sample size 126
Population Elderly adults recruited from the Emory Cognitive Clinic, including Alzheimer disease (n=60), frontotemporal dementia (n=21), dementia with Lewy bodies (n=20), and cognitively normal controls (n=25)
Topics Dreaming
Keywords Alzheimer disease Dementia Dreams Nightmares Hypocretin
Key findings CSF hypocretin levels did not distinguish between dementia syndromes and were normal in most participants. Lower hypocretin levels were associated with more frequent nightmares and vivid dreams, suggesting disturbing dreams in dementia patients may be related to lower hypocretin concentrations.

Abstract

Background/aims: Hypocretin promotes wakefulness and modulates REM sleep. Alterations in the hypocretin system are increasingly implicated in dementia. We evaluated relationships among hypocretin, dementia biomarkers, and sleep symptoms in elderly participants, most of whom had dementia.

Methods: One-hundred twenty-six adults (mean age 66.2 ± 8.4 years) were recruited from the Emory Cognitive Clinic. Diagnoses were Alzheimer disease (AD; n = 60), frontotemporal dementia (FTD; n = 21), and dementia with Lewy bodies (DLB; n = 20). We also included cognitively normal controls (n = 25). Participants and/or caregivers completed sleep questionnaires and lumbar puncture was performed for cerebrospinal fluid (CSF) assessments.

Results: Except for sleepiness (worst in DLB) and nocturia (worse in DLB and FTD) sleep symptoms did not differ by diagnosis. CSF hypocretin concentrations were available for 87 participants and normal in 70, intermediate in 16, and low in 1. Hypocretin levels did not differ by diagnosis. Hypocretin levels correlated with CSF total τ levels only in men (r = 0.34; p = 0.02). Lower hypocretin levels were related to frequency of nightmares (203.9 ± 29.8 pg/mL in those with frequent nightmares vs. 240.4 ± 46.1 pg/mL in those without; p = 0.05) and vivid dreams (209.1 ± 28.3 vs. 239.5 ± 47.8 pg/mL; p = 0.014). Cholinesterase inhibitor use was not associated with nightmares or vivid dreaming.

Conclusion: Hypocretin levels did not distinguish between dementia syndromes. Disturbing dreams in dementia patients may be related to lower hypocretin concentrations in CSF.

Comparable studies

Other cross-sectional and survey studies on dreaming, most cited first.

Study Year Design Participants
Insomnia Symptoms, Nightmares, and Suicidal Ideation in a College Student Sample Undergraduate students at a large, public university in the southeastern United States 2011 Observational cross-sectional survey n = 583
Prevalence and Correlates of Frequent Nightmares: A Community-Based 2-Phase Study Middle-aged Hong Kong Chinese adults from the community, mean age 40.9 years (SD 5.5,... 2010 Cross-sectional survey with subsequent clinical evaluation (two-phase design) n = 8,558
Factors of home dream recall: a structural equation model Adults (general population sample) 2003 Cross-sectional survey with structural equation modeling n = 444
The Phenomenology of Lucid Dreaming: An Online Survey Respondents to an online survey about lucid dreams 2014 Online survey n = 684
Frequency of Lucid Dreaming in a Representative German Sample Representative sample of German adults 2011 Cross-sectional survey n = 919

Citations in the library

Explore topics